Terbinafine HCl Tablets are the generic version of Novartis’ Lamisil tablets, which are used for fungal infections.
Terbinafine HCl tablets had US sales of approximately $685 million for the 12 months ending March 31, 2007, for the same strength, according to the company.
The product will be shipped immediately.